Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chong-Jen Yu

Showing results (381-390 of 478) with videos related to

Pageof 48
Sort By:
Oncotargets and Therapy|June 13, 2014
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinomaJeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 18, 2012
Immunogenicity and safety of an AS03(A)-adjuvanted H5N1 influenza vaccine in a Taiwanese populationShinn-Jang Hwang, Shan-Chwen Chang, Chong-Jen Yu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Different efficacies of erlotinib and gefitinib in taiwanese patients with advanced non-small cell lung cancer: a retrospective multicenter studyWen-Chien Fan, Chong-Jen Yu, Chun-Ming Tsai, et al.
Frontiers in Immunology|June 4, 2021
Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003Wen-Pin Tseng, Jhong-Lin Wu, Chen-Chi Wu, et al.
BMC Infectious Diseases|July 26, 2013
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 yearsDorothee Kieninger, Eric Sheldon, Wen-Yuan Lin, et al.
Scientific Reports|January 26, 2016
Effects of acute critical illnesses on the performance of interferon-gamma release assayChun-Ta Huang, Sheng-Yuan Ruan, Yi-Ju Tsai, et al.
Neoplasia (New York, N.Y.)|December 22, 2024
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasisSheng-Kai Liang, Wei-Yu Liao, Jin-Yuan Shih, et al.
Therapeutic Advances in Medical Oncology|November 3, 2022
Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinomaChia-Ling Chang, Min-Shu Hsieh, Jin-Yuan Shih, et al.
Cancer|January 12, 2021
Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 studyKeunchil Park, Pasi A Jӓnne, Dong-Wan Kim, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 13, 2019
Weaning outcome of solid cancer patients requiring mechanical ventilation in the intensive care unitEmily Han-Chung Hsiue, Pei-Lin Lee, Yung-Hsuan Chen, et al.
Pageof 48

Showing results (381-390 of 478) with videos related to

Sort By:
Pageof 48
Oncotargets and Therapy|June 13, 2014
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinomaJeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 18, 2012
Immunogenicity and safety of an AS03(A)-adjuvanted H5N1 influenza vaccine in a Taiwanese populationShinn-Jang Hwang, Shan-Chwen Chang, Chong-Jen Yu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Different efficacies of erlotinib and gefitinib in taiwanese patients with advanced non-small cell lung cancer: a retrospective multicenter studyWen-Chien Fan, Chong-Jen Yu, Chun-Ming Tsai, et al.
Frontiers in Immunology|June 4, 2021
Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003Wen-Pin Tseng, Jhong-Lin Wu, Chen-Chi Wu, et al.
BMC Infectious Diseases|July 26, 2013
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 yearsDorothee Kieninger, Eric Sheldon, Wen-Yuan Lin, et al.
Scientific Reports|January 26, 2016
Effects of acute critical illnesses on the performance of interferon-gamma release assayChun-Ta Huang, Sheng-Yuan Ruan, Yi-Ju Tsai, et al.
Neoplasia (New York, N.Y.)|December 22, 2024
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasisSheng-Kai Liang, Wei-Yu Liao, Jin-Yuan Shih, et al.
Therapeutic Advances in Medical Oncology|November 3, 2022
Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinomaChia-Ling Chang, Min-Shu Hsieh, Jin-Yuan Shih, et al.
Cancer|January 12, 2021
Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 studyKeunchil Park, Pasi A Jӓnne, Dong-Wan Kim, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 13, 2019
Weaning outcome of solid cancer patients requiring mechanical ventilation in the intensive care unitEmily Han-Chung Hsiue, Pei-Lin Lee, Yung-Hsuan Chen, et al.
Pageof 48